ArticleStem cells translational medicine2020

CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes.

John W Ostrominski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.